The FDA has notified healthcare professionals that a Boxed Warning is being added to the prescribing information for promethazine hydrochloride products, describing the risks of severe tissue injury, ...
September 16, 2009 — The US Food and Drug Administration (FDA) is requiring manufacturers of the injectable form of promethazine hydrochloride to add a boxed warning to the drug's labeling that ...
Promethazine HCl 25mg/mL, 50mg/mL; sol for IM or IV inj; contains sulfites. Sulfite sensitivity. CNS depression. Impaired respiratory function (eg, COPD, sleep apnea). Narrow-angle glaucoma. GI or GU ...
Promethazine (Phenergan INJ (25mg)) is an antihistamine and antiemetic, prescribed for allergic conditions, prevention of motion sickness, and to control nausea and vomiting during and after ...
Promethazine (Phenadoz, Phenergan, Promethegan) can cause gangrene and should only be used in a deep intramuscular injection, according to a warning from the U.S. FDA. Promethazine is used in ...
Promethazine (Phena - Kid ) is an antihistamine and antiemetic, prescribed for allergic conditions, prevention of motion sickness, and to control nausea and vomiting during and after surgery.It ...
Jan. 26, 2005 — The U.S. Food and Drug Administration (FDA) approved in November 2004 revisions to safety labeling to advise healthcare professionals of the following changes: valdecoxib use is ...
Parents have been warned not to give their young children the popular oral antihistamine, promethazine hydrochloride — sold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results